crataegus extract: Clinical Trials

6 trials of crataegus extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Phase 11Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow crataegus extract: new trials by email Literature Review of crataegus extract trials Research Report on crataegus extract

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
Flore - Autism Spectrum Disorder
Not applicableCompletedArizona State University2962020-10-152026-04-09
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
Hawthorn, SGAs - Schizophrenia
Not applicableCompletedCalo Psychiatric Center1352013-01-012018-09-10
Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias
Ritmonutra, placebo - Ventricular and Atrial Extrasytoles
Phase 4CompletedFederico II University15002012-12-012016-02-03
Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract
Hawthorn, Placebo capsule - Prehypertension, Mild Hypertension
Phase 1CompletedUniversity of North Carolina, Chapel Hill242010-05-012013-02-07
Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety
Passiflora ; Crataegus and Salix, Valeriana - Anxiety Disorder
Phase 3CompletedMarjan Industria e Comercio ltda1502009-09-012014-07-08
Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn
Digoxin, Hawthorn - Heart Diseases
Not applicableCompletedNational Center for Research Resources (NCRR)2005-06-24

Conditions studied

Anxiety Disorders (1)  ·  Arrhythmias, Cardiac (1)  ·  Autism Spectrum Disorder (1)  ·  Dyslipidemias (1)  ·  Heart Diseases (1)  ·  Prehypertension (1)  ·  Schizophrenia (1)

Sponsors

Arizona State University (1)  ·  Calo Psychiatric Center (1)  ·  Federico II University (1)  ·  Marjan Industria e Comercio ltda (1)  ·  National Center for Research Resources (NCRR) (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (3)  ·  Brazil (1)  ·  Italy (1)

Top investigators

Antonio C Lopes, Phd (1)  ·  Bruno Trimarco, MD (1)  ·  Gary N Asher, MD, MPH (1)  ·  Maria Elisabete A Moraes, MD (1)

Results publications

PMID 20498621, PMID 22458601

NIH funding

M01RR000042 (1)